Table:
begin	end	state
1	31	cytoplasmic
32	53	transmembrane
54	63	non-cytoplasmic
64	87	transmembrane
88	98	cytoplasmic
99	118	transmembrane
119	122	non-cytoplasmic
123	147	transmembrane
148	166	cytoplasmic
167	191	transmembrane
192	200	non-cytoplasmic
201	219	transmembrane
220	260	cytoplasmic
261	279	transmembrane
280	298	non-cytoplasmic
299	319	transmembrane
320	327	cytoplasmic
328	347	transmembrane
348	352	non-cytoplasmic
353	377	transmembrane
378	388	cytoplasmic
389	412	transmembrane
413	417	non-cytoplasmic
418	439	transmembrane
440	500	cytoplasmic

Input:
>GFF2891 FitnessBrowser__WCS417:GFF2891
MKLRKKSVKPIGLKDITIVDDTKVRKAITAAALGNAMEWFDFGVYGFVAYVLGKVFFPDA
SPSVQMIAALGTFSVPFLIRPLGGLFFGALGDKYGRQKVLAATIVIMSLSTFAIGLIPSY
ASIGIWAPILLLLCKMAQGFSVGGEYTGASIFVAEYAPDRKRGFLGSWLDFGSIAGFVLG
AGVVVLISSILGEADFESWGWRLPFFLALPLGIIGLYLRHALEETPAFQQHMDKMEQGDR
EGLTHGPKVSFKEVATKHWRSLLTCIGIVAATNVTYYMLLTYMPSYLSHNLHYKENSGVL
IIIAIMVGMLFVQPFIGFISDKIGRKPFIIAGSIGLLFLSIPAFMLITSGKIGLIFAGLL
ILAVILNFFIGVMASTLPAMFPTHLRYSALASAFNVSVLIAGLTPTAVAWLVESTNDLYM
PAYYLMVFAVVGLITGLTMKETANKPLRGAAPAASDMEEAKELLQEHHDNIEQKIEDIDA
EIAELEAKRKNLVEQHPRIN

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server